Amoud university for health and science institute 6/29/2014 Dr mukhtar jama nour,MBBS 1 What is multiple myeloma?
It is a malignant disease of the plasma cells of bone marrow.
Remains an incurable disease. 6/29/2014 Dr mukhtar jama nour,MBBS 2 What is the most common monoclonal protein found in MM? IgG (55%) IgA (20%)
In approximately 20% there is no paraproteinaemia, only light chains in the urine.(Bence jones proteins) 6/29/2014 Dr mukhtar jama nour,MBBS 3 What are the risk factors for MM? Age >60. Exposure to pesticides. Radiation Benzene HSV8 (Kaposis sarcoma Herpes Virus)
6/29/2014 Dr mukhtar jama nour,MBBS 4 What are the clinical features of MM? Disease of elderly. Median age >60 More common in black Africans.
Bone destruction Renal failure Bone marrow infiltration
6/29/2014 Dr mukhtar jama nour,MBBS 5 May be symptomatic or asymptomatic.
Symptomatic myeloma characterized by presence of ROTI and CRAB.
Myeloma Related Organ or Tissue Impairment.
Calcium levels increased Renal failure Anemia Bone lesion
6/29/2014 Dr mukhtar jama nour,MBBS 6 What is the cause for renal failure in MM? Deposition of light chains in the tubules (most common).
Also: hypercalcaemia, hyperuricaemia, use of NSAIDs (rarely) and deposition of amyloid.
6/29/2014 Dr mukhtar jama nour,MBBS 7 What is the consequence of bone marrow infiltration with plasma cells? anaemia neutropenia Thrombocytopenia Production of paraproteins. 6/29/2014 Dr mukhtar jama nour,MBBS 8 What is the consequence of bone destruction in MM? 6/29/2014 Dr mukhtar jama nour,MBBS 9 Fracture of long bones Vertebral collapse Hypercalcemia
6/29/2014 Dr mukhtar jama nour,MBBS 10 In MM which bone activity is increased? Osteoblast or osteoclast? 6/29/2014 Dr mukhtar jama nour,MBBS 11 Increased osteoclastic activity.
That is why biphosphonates is useful in MM because it inhibits osteoclastic activity. 6/29/2014 Dr mukhtar jama nour,MBBS 12 Why do patients with MM get recurrent infections?
6/29/2014 Dr mukhtar jama nour,MBBS 13 Because there is a reduction in the normal immunoglobulin levels (immuneparesis), contributing to the tendency for patients with myeloma to have recurrent infections. 6/29/2014 Dr mukhtar jama nour,MBBS 14 diagnosis What are the imaging studies used to diagnose MM? 6/29/2014 Dr mukhtar jama nour,MBBS 15 Skeletal survey-lytic lesion. easily seen in skull. CT, MRI and PET are used in plasmacytomas (bone or soft tissue deposits). MRI spine- may show imminent compression/collapse.
6/29/2014 Dr mukhtar jama nour,MBBS 16 Thoracic compresion fracture due to MM 6/29/2014 Dr mukhtar jama nour,MBBS 17 Myeloma affecting the skull. Note the rounded lytic translucencies produced by infiltration of the skull with myeloma cells. 6/29/2014 Dr mukhtar jama nour,MBBS 18 FBC- normal or low. ESR, CRP-almost always raised. U&Es, Cr-renal failure Raised LDH Serum calcium- normal or raised. Serum ALP-normal Uric acid-normal or raised Bone marrow aspirate or trephine shows infiltration by plasma cells Amyloid may be found.
6/29/2014 Dr mukhtar jama nour,MBBS 19 Two out of three diagnostic features should be present: paraproteinaemia or Bence Jones protein radiological evidence of lytic bone lesions an increase in bone marrow plasma cells. 6/29/2014 Dr mukhtar jama nour,MBBS 20 What is the treatment for MM? 6/29/2014 Dr mukhtar jama nour,MBBS 21 supportive care chemotherapy Autologous or allogeneic stem cell transplantation. 6/29/2014 Dr mukhtar jama nour,MBBS 22 What is the supportive therapy? 6/29/2014 Dr mukhtar jama nour,MBBS 23 Treat the anemia-erythropoetin helps. Treat the infection Radiotherapy/sytemic chemo/high dose for bone pain. vertebroplasty for treating vertebral fractures. Biphosphonates (pamidronate/zoledronic acid).
6/29/2014 Dr mukhtar jama nour,MBBS 24 For elderly What are the chemo options? If not fit for transplant, treat with Melphalan + Prednisone + Thalidomide (MPT).
6/29/2014 Dr mukhtar jama nour,MBBS 25 For younger patients High-dose dexamethasone based induction.
Followed by high-dose melphalan with peripheral blood stem cell rescue (auto transplantation)
Stem cell transplant- improves survival but not curative. median survival increasing to 6 years. 6/29/2014 Dr mukhtar jama nour,MBBS 26 6/29/2014 Dr mukhtar jama nour,MBBS 27